Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the β-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high-HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full-length forms of BCL11A is developmentally restricted to adult erythroid cells. Down-regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the β-globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in β-hemoglobin disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The retention of both HBG genes, each with slightly different promoter sequences, also contributes to nuanced regulatory control and may influence HbF levels in adults, a feature of clinical relevance in disorders like β-thalassemia and sickle cell disease [97].”
From Origin and Evolution of Genes in Eukaryotes: Mechanisms, Dynamics, and Functional Implications (2025) · cites this paper as [97]
In the citing paper
“Reducing bcl11a expression in transgenic sickle mice derepressed g-globin genes.17,18”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [17]
In the citing paper
“current treatments aim to induce the expression of non-mutated fetal hemoglobin (HbF), which is functional but transcriptionally repressed post-birth (Sankaran et al. 2008).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Sankaran et al. 2008
In the citing paper
“Further molecular studies revealed that BCL11A interacts with several erythroid regulators including GATA1, FOG1, and SOX6, and with the nucleosome remodeling and deacetylase complex (NuRD) (4, 6).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
In the citing paper
“We identi fi ed numerous peptides of BCL11A and nearly all previously established interacting proteins, including FOG1, the entire NuRD complex, and the nuclear matrix protein MATRIN-3 (4).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Self-citationA Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E., et al. (2007) · Nature · doi:10.1038/nature06014 · Cited by 1,604
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Tsai, S.-F., Martin, D. I. K., Zon, L. I., D'Andrea, A. D., Wong, G. G., & Orkin, S. H. (1989) · Nature · doi:10.1038/339446a0 · Cited by 885
Self-citationTsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., & Orkin, S. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80318-9 · Cited by 712
Self-citationUda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Self-citationLettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Self-citationA QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes
Göring, H. H. H., Curran, J. E., Johnson, M. P., Dyer, T. D., Charlesworth, J., Cole, S. A., Jowett, J. B. M., Abraham, L. J., Rainwater, D. L., Comuzzie, A. G., et al. (2007) · Nature Genetics · doi:10.1038/ng2119 · Cited by 504
Cited by
Items 701–800 of 1,001
p27Kip1 regulates γ-globin production
Balbin-Cuesta, G., Drysdale, C. M., Kerpet, C., Yu, L., Myers, G., Lin, Z., McGee, B. M., Friedman, A. D., Liu, X., Singh, S. A., et al. (2025) · Blood · doi:10.1182/blood.2025028895 · Cited by 5
Chauhan, W., & Zennadi, R. (2026) · Antioxidants · doi:10.3390/antiox15030324 · Cited by 5
Piel, F. B., de Montalembert, M., Das, R., Kuo, K. H. M., Taher, A. T., Musallam, K. M., Treadwell, M. J., Fucharoen, S., Angastiniotis, M., Higgs, D. R., et al. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00722-w · Cited by 5
TR4 and BCL11A repress γ-globin transcription via independent mechanisms
Wang, Y., Myers, G., Yu, L., Deng, K., Balbin-Cuesta, G., Singh, S. A., Guan, Y., Khoriaty, R. N., & Engel, J. D. (2024) · Blood · doi:10.1182/blood.2024024599 · Cited by 5
Chumchuen, S., Pornsukjantra, T., Innachai, P., Khamphikham, P., Wongborisuth, C., Anurathapan, U., Songdej, D., Sripichai, O., Tangprasittipap, A., & Hongeng, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-30762-3 · Cited by 5
Xue, Y., Su, J., Chao, Y., Liu, L., Lin, X., Xiang, Y., Ho, M. K., Su, Z., Chen, J., Luo, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.202518084 · Cited by 5
Clinically‐oriented proteomic investigation of sickle cell disease: Opportunities and challenges
Renella, R. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500133 · Cited by 5
Warren, A. J. (2017) · Blood · doi:10.1182/blood-2016-12-755538 · Cited by 5
Acute soft head syndrome in a teenager with sickle cell anemia: A case report
Magitta, N. F., Komanya, F. B., Alphonce, B., Bitesigilwe, M., Sindato, E. M., & Meda, J. (2023) · Clinical Case Reports · doi:10.1002/ccr3.8174 · Cited by 5
Vitamin C derivative/AA2P promotes erythroid differentiation by upregulating CA1
Tan, X., Li, M., Liang, Y., Ruan, X., Zhang, Z., & Fang, X. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad043 · Cited by 5
Xie, D., Han, Y., Zhang, W., Wu, J., An, B., Huang, S., & Sun, F. (2024) · Hemoglobin · doi:10.1080/03630269.2023.2284950 · Cited by 5
Listì, F., Sclafani, S., Agrigento, V., Barone, R. M. E., Maggio, A., & D’Alcamo, E. (2018) · Hemoglobin · doi:10.1080/03630269.2018.1482832 · Cited by 5
Lai, Z.-S., Yeh, T., Chou, Y., Hsu, T., Lu, C., Kung, F.-C., Hsieh, M.-Y., Lin, C., Chen, C., Shen, C.-K. J., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112938 · Cited by 5
Bonello‐Palot, N., Cérino, M., Joly, P., & Badens, C. (2016) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(16)30130-7 · Cited by 5
Adams, T. L., Latham, G. J., Eisses, M. J., Bender, M. A., & Haberkern, C. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-42974-0.00010-0 · Cited by 5
Intrinsic regulation of hemoglobin expression by variable subunit interface strengths
Manning, J. M., Popowicz, A. M., Padovan, J. C., Chait, B. T., & Manning, L. R. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08437.x · Cited by 5
Current therapeutic landscape of β-thalassemia: focus on gene therapy
Cheng, A. N., & Kwiatkowski, J. L. (2026) · Therapeutic Advances in Rare Disease · doi:10.1177/26330040261433028 · Cited by 4
Udeze, C., Gargano, M. A., Yang, H., Ogunsile, F. J., Li, N., Fang, H., Jeyakumar, S., & Lopez, A. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2649528 · Cited by 4
Mapping Polymerization and Allostery of Hemoglobin S Using Point Mutations
Weinkam, P., & Šali, A. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4025156 · Cited by 4
Cai, D.-L., Chan, Y., Kong, Y.-M., Liu, Y., Guo, Y. P., Cai, A.-Q., & Zhu, B. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176404 · Cited by 4
Rapid detection of genetic modifiers of β-thalassemia based on MALDI-TOF MS
Huang, L., Zhang, Q., Ye, Y., Long, Y., Huang, H., Niu, C., Lin, B., Zeng, L., Wang, Y., Dai, T., et al. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06277-2 · Cited by 4
Effects of divalproex sodium on hemoglobin level
Taher, A. T., Musallam, K. M., Nasreddine, W., Perrine, S. P., El-Hajj, T., & Beydoun, A. A. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.01.015 · Cited by 4
Genetic polymorphisms and protein levels in vocal fold leukoplakia: a systematic review
Campello, C. P., Lima-Silva, M. F. B., de Lima, E. L. S., Nunes, G. R. S., Silva, H. A. M., Dellalibera, E., de Britto, L. R. P. B., Lemos, C. A. A., & Muniz, M. T. C. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e11920 · Cited by 4
Soomro, N., Wahid, M., Mehmood, M., & Danish, S. H. (2023) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.39.6.7183 · Cited by 4
The Role of Genetics in Advancing Cardiometabolic Drug Development
Abou-Karam, R., Cheng, F., Gady, S., & Fahed, A. C. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01195-6 · Cited by 4
Role of B-Cell Lymphoma/Leukemia 11A in Normal and Malignant Hematopoiesis
Zhang, H., Zeng, J., Zhang, F., Liu, J., & Liang, L. (2025) · Biology · doi:10.3390/biology14010026 · Cited by 5
Buccheri, M. A., Spina, S., Ruberto, C., Lombardo, T., Labie, D., & Ragusa, A. (2013) · Hemoglobin · doi:10.3109/03630269.2013.800823 · Cited by 4
BCL11Acontrôle l’expression de l’hémoglobine fœtale
Labie, D. (2012) · médecine/sciences · doi:10.1051/medsci/20122811007 · Cited by 4
Future Perspectives for the Treatment of Sickle Cell Anemia
Nottage, K. A., Estepp, J. H., & Hankins, J. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_16 · Cited by 4
High level of fetal-globin reactivation by designed transcriptional activator-like effector
Zhan, J., Irudayam, M. J., Nakamura, Y., Kurita, R., & Nienhuis, A. W. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000482 · Cited by 4
Ndour, E. H. M., Mnika, K., Tall, F. G., Seck, M., Ly, I. D., Nembaware, V., Sagna-Bassène, H. A. T., Dione, R., Ndongo, A. A., Diop, J. P. D., et al. (2022) · PubMed · Cited by 4
RNA Silencing: An Approach for the Treatment of β-Thalassemia
Urkude, V., & Amit, M. (2012) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000135 · Cited by 4
Mahdavi, M. R., Pourfarzad, F., Kosaryan, M., & Akbari, M. T. (2017) · PubMed Central · Cited by 4
The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment
Lai, M. I., & Ahmed, N. H. M. (2022) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x23666230123140926 · Cited by 4
Suwito, B. E., Adji, A. S., Widjaja, J. S., Angel, S. C. S., Hajiri, A. Z. Z. A., Salamy, N. F. W., & Choirotussanijjah, C. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.11435 · Cited by 4
Hemoglobin Gene Therapy for β-Thalassemia
Bank, A. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.002 · Cited by 4
Is blood transfusion therapy the ideal treatment for β-thalassemia intermedia?
Constantinou, K. (2012) · Open Journal of Hematology · doi:10.13055/ojhmt_3_1_5.121117 · Cited by 4
Systems biomedicine: It’s your turn —Recent progress in systems biomedicine
Zhang, Z., Zhao, Z., Liu, B., Li, D., Zhang, D., Chen, H., & Liu, D. (2013) · Quantitative Biology · doi:10.1007/s40484-013-0009-z · Cited by 4
Gambari, R. (2014) · Thalassemia Reports · doi:10.4081/thal.2014.4877 · Cited by 4
Rahaman, M., Bhowmick, C., Komanapalli, J., Mukherjee, M., Byram, P. K., Shukla, P. C., Dolai, T. K., & Chakravorty, N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.13.464339 · Cited by 4
Hara, Y., Kawabata, E., Lemgart, V. T., Bronson, P. G., Hicks, A., Peters, R., Krishnamoorthy, S., Ribeil, J., Schmunk, L. J., Eglinton, J., et al. (2023) · medRxiv · doi:10.1101/2023.03.14.23287244 · Cited by 4
Maroofi, N., Maleki, M. S. M., Tahmasebi, M., Khorshid, H. R. K., Modaberi, Y., Najafipour, R., & Banan, M. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01155-0 · Cited by 3
Jang, Y., Eom, Y. J., Gwak, S.-H., Koh, Y., Han, J., Rim, Y. A., Nam, Y., & Ju, J. H. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04825-1 · Cited by 3
The expanding therapeutic landscape of β-thalassaemia
Musallam, K. M., Sheth, S., Locatelli, F., Shah, F., Rivella, S., Kuo, K. H. M., Forni, G. L., Kattamis, A., Aydınok, Y., Glenthøj, A. B., et al. (2026) · The Lancet Haematology · doi:10.1016/s2352-3026(26)00173-0 · Cited by 3
Analysis of rs4671393 Polymorphism in Hemoglobin E/β-thalassemia Major in Guangxi Province of China
He, Y., Chen, P., Lin, W., & Luo, J. (2012) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3182370bff · Cited by 3
miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation
Simbula, M., Manchinu, M. F., Mingoia, M., Pala, M., Asunis, I., Caria, C. A., Perseu, L., Shah, M., Crossley, M., Moi, P., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.09.002 · Cited by 3
Liu, Q., Lin, Z., Yue, M., Wu, J., Li, L., Huang, D., Fang, Y., Zhang, X., & Hao, T. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1365232 · Cited by 3
Takezaki, M., Li, Y., Xu, H., Patel, N., Lucas, R., Cerbone, R. E., Koti, S., Hendrick, C. L., Junker, L. H., & Pace, B. S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323550 · Cited by 3
Epigenetic Regulation of Globin Genes and Disturbances in Hemoglobinopathies
Saunthararajah, Y., Lavelle, D., & DeSimone, J. (2013) · Springer eBooks · doi:10.1007/978-3-642-38404-2_4 · Cited by 3
Multi-Locus Models to Address Hb F Variability in Portuguese β-Thalassemia Carriers
Manco, L., Bento, C., Relvas, L., Cunha, E., Pereira, J., Moreira, V., Álvarez, M., Maia, T. M., & Ribeiro, M. L. (2020) · Hemoglobin · doi:10.1080/03630269.2020.1753766 · Cited by 3
Jin, T., Zhang, Z., Han, Y., Li, D., Liu, J., Jiang, M., Zhu, J., Kurita, R., Nakamura, Y., Hu, F., et al. (2022) · Journal of Immunology Research · doi:10.1155/2022/8440422 · Cited by 3
Beuchel, C. F., Dittrich, J., Becker, S., Kirsten, H., Tönjes, A., Kovacs, P. L., Stümvoll, M., Loeffler, M., Teren, A., Thiery, J., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02362-z · Cited by 3
A Systems Approach to Blood Disorders
Qasba, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2095-2_19 · Cited by 3
BCL11A Polymorphism in Egyptian Children with β-Thalassemia: Relation to Phenotypic Heterogeneity
Salah, N. Y., Ali, H. G. A., Bassiouny, N., Salem, L. E. M. A., Taha, S., Youssef, M. K., Annaka, L., & Barakat, N. M. (2021) · Journal of Pediatric Genetics · doi:10.1055/s-0041-1728744 · Cited by 3
Endogenous CO Production in Sickness and in Health
(2022) · Wiley eBooks · doi:10.1002/9781119783435.ch1 · Cited by 3
Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Tian, R., Li, F., Che, S., Song, M., Liu, L., Guo, R., Li, Z., Hu, X., & Zhang, H. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/8030243 · Cited by 3
RetractedThe Hemoglobin Regulatory Regions
Pace, B. S., & Makala, L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1683-8_2 · Cited by 3
Gao, J., Liu, J., Zhang, L., Zhang, Y., Guo, Q., Li, Y., Tong, J., Wang, H., Zhou, J., Zhu, F., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111780 · Cited by 3
Daniel-Moreno, A., Lamsfus‐Calle, A., Wilber, A. C., Chambers, C. B., Johnston, I., Antony, J. S., Epting, T., Handgretinger, R., & Mezger, M. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102456 · Cited by 3
Inherited Hemoglobin Disorders
Munshi, A. (2015) · InTech eBooks · doi:10.5772/59742 · Cited by 3
Consensus Predictive Model for Human K562 Cell Growth Inhibition through Enalos Cloud Platform
Afantitis, A., Leonis, G., Gambari, R., & Melagraki, G. (2017) · ChemMedChem · doi:10.1002/cmdc.201700675 · Cited by 3
Characterisation of Duplicated Haemoglobin Genes in Bivalves
Klein, M. E. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.107921 · Cited by 3
High-efficiency HDR in immortalized cell lines by crude rAAV mediated donor template deliveryPreprint
Mehta, S., Buyanbat, A., Zheng, G., Liu, N., & Orkin, S. H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.02.490359 · Cited by 3
Self-citationExpansion of human hematopoietic stem cells by inhibiting translationPreprint
Li, C., Shin, H., Bhavanasi, D., Liu, M., Briones, M. I., Liu, X., Liu, X., Herbst, F., Said, H., Alameh, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568925 · Cited by 3
The BCL11A transcription factor stimulates the enzymatic activities of the OGG1 DNA glycosylase
Petrachkova, T., Солдаткина, О. И., Leduy, L., & Nepveu, A. (2024) · Biological Chemistry · doi:10.1515/hsz-2024-0088 · Cited by 2
Schaefer, M. A., Gomez, S. L., Dogiparthi, V. R., Zhou, Y., Roy, P., Ray, S., Chee, L., Brahma, S., Liefke, R., & Hewitt, K. J. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015627 · Cited by 2
Three-dimensional genome reorganization in hematopoietic stem cells
Nakajima, A., Kirito, K., Nakanishi, M., & Takayama, N. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.105249 · Cited by 2
HbF-inducing gene therapies for the β-hemoglobinopathies: implications for future pregnancies
Gavillet, M., Legardeur, H., Adam, C. J. M., Renella, R., Dashraath, P., & Baud, D. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100047 · Cited by 2
Ginder, G. D., Shang, S., & Williams, D. C. (2026) · Blood · doi:10.1182/blood.2025031153 · Cited by 2
Alotaibi, D., Aldagdog, F., Alramadhan, S. I., Almuhaidib, B., Asiri, N., Almodhi, L., Alshabaan, M., Alborhan, R., Vatte, C., Mohiuddin, S. S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031203 · Cited by 2
Genetic influences on haematopoiesis
Poeschla, M., & Sankaran, V. G. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00947-1 · Cited by 3
Self-citationNo Time to Fold: Intrinsically Disordered Microproteins in Action
Chen, T., Cao, K., & Martinez, T. F. (2026) · Biochemistry · doi:10.1021/acs.biochem.6c00280 · Cited by 2
Chumchuen, S., Sripichai, O., Jearawiriyapaisarn, N., Fucharoen, S., & Peerapittayamongkol, C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281059 · Cited by 2
Conway, A. J., Rosanwo, T. O., Williamson, T. E., Landry, S. B., Kinney, M. A., Clark, M. A., Vo, L. T., Rowe, R. G., Marion, W., Zhang, Y., et al. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.105264 · Cited by 2
Genomic Study in β-Thalassemia
Svasti, S., Sripichai, O., Nuinoon, M., Winichagoon, P., & Fucharoe, S. (2011) · InTech eBooks · doi:10.5772/23545 · Cited by 2
Personalized Medicine and Blood Disorders
Zhang, L. (2016) · Personalized Medicine · doi:10.2217/pme-2016-0043 · Cited by 2
Non-Coding RNA: An Emerging Modulator of ꞵ-Globin Regulation and ꞵ-Hemoglobinopathies
Ali, H., & Khan, F. (2022) · Molecular Medicine Communications · doi:10.55627/mmc.002.002.0147 · Cited by 2
Luo, H., Wang, J., Qin, L., Zhang, X., Liu, H., Niu, C., Song, M., Shao, C., Xu, P., Yu, M., et al. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.10.015 · Cited by 2
Nitric Oxide / Cyclic Nucleotide Regulation of Globin Genes in Erythropoiesis
Vladan, P., Bojana, B., Jovi, G., Raj, K., & Alan, N. (2012) · InTech eBooks · doi:10.5772/34534 · Cited by 2
Lulli, V., Romania, P., Morsilli, O., Ilari, R., Gabbianelli, M., Testa, U., & Marziali, G. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.10.004 · Cited by 2
From genome-wide association study hits to new insights into experimental hematology
Cvejic, A. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.04.005 · Cited by 2
Müller, L., Milsom, M. D., & Williams, D. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7656-7_6 · Cited by 2
A potential role of fetal hemoglobin in the development of multidrug resistance
Fyrberg, A., Skoglund, K., Wolk, M., & Lotfi, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.129 · Cited by 2
RNA therapeutics for β-thalassemia
Duong, H., Nguyen, T.-H., Hoang, M.-C., Ngo, V.-L., & Le, V.-T. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.006 · Cited by 2
Enhancers and super-enhancers in human disease and therapy
Hoke, H. A. (2014) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 2
Hematopoietic Cell Transplantation for Sickle Cell Disease
Walters, M. C. (2003) · Wiley eBooks · doi:10.1002/9780470987070.ch104 · Cited by 2
Modifier Genes in the Haemoglobinopathies
Marzo, R. D., Calzolari, R., Rund, D. G., & Maggio, A. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022443 · Cited by 2
Gene Therapy for Severe Haemoglobin Disorders
Villamizar, O., Chambers, C. B., & Wilber, A. C. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025829 · Cited by 2
Molecular scissors cut in on stem cells
Azvolinsky, A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0467-6 · Cited by 2
ZNF410 represses fetal globin by devoted control of CHD4/NuRDPreprint
Vinjamur, D. S., Yao, Q., Cole, M. A., McGuckin, C., Ren, C., Zeng, J., Hossain, M., Luk, K., Wolfe, S. A., Pinello, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.31.272856 · Cited by 2
Genome editing coming of age for hemoglobinopathy
Jiang, H. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.007 · Cited by 2
Alattar, A. G. (2024) · Lund University Publications (Lund University) · Cited by 2
Ameliorating β-thalassaemia by manipulating expression of the α-globin gene
Mettananda, S. (2015) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-g7oz2q7pe · Cited by 2
Under the hood: The molecular biology driving gene therapy for the treatment of sickle cell disease
Waldron, E., & Tanhehco, Y. C. (2022) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2022.103566 · Cited by 1
Genetic modifications of EGLN1 reactivate HbF production in β0-thalassemia/HbE
Jan‐ngam, V., Boontha, S., Tubsuwan, A., Wongpalee, S. P., Fanhchaksai, K., Tantiworawit, A., Charoenkwan, P., & Khamphikham, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38020 · Cited by 1
BCL-11 enables adaptive stress responses to environmental challenges
Niedworok, P., Ciliberti, R. E., Xie, B., Mathew, A. J., Jussila, B., Lawson, J. A., Domenico, E. D., Paulusch, S., Beyer, M., Nicotera, P., et al. (2026) · iScience · doi:10.1016/j.isci.2025.114422 · Cited by 1
Gene Therapy for Sickle Cell Disease
Dansereau, C. (2026) · Journal of Pediatric Hematology/Oncology Nursing · doi:10.1177/27527530251400731 · Cited by 1
New Gene Therapy Strategy for β-Thalassemia
Liang, D., Schmidt‐Wolf, I. G. H., & Pu, J. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11132-6 · Cited by 1
Arji, S., Shen, Z., Welch, S., ElMahdaoui, F., Bahadur, A., Lee, E., Lee, H., Wu, S.-C. P., Konshina, E., Ayubali, B., et al. (2026) · Biomarker Research · doi:10.1186/s40364-026-00911-5 · Cited by 1
Gradilla, P. R., Ferrer, S., Montero, B. O., Nieto, J. M., González, F. A., Villegas, A., & Cuesta, C. B. (2026) · ANALES RANM · doi:10.32440/ar.2026.143.01.rev03 · Cited by 1
Metadata
- Authors
- Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H.
- Affiliations
- Broad Institute (US)
- Division of Hematology/Oncology, Children's Hospital Boston, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
- Corresponding author
- Orkin, Stuart H.
- ORCID
- Venue
- Science
- Published
- 2008-12-19
- Volume
- 322
- Issue
- 5909
- Pages
- 1839-1842
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1968165696
- Semantic Scholar
- a52e99500fd26811a2ae248d6dce95e3152b5bb7
- Cited by
- 919
- References
- 27
- Citations by year
- 2026: 59 · 2025: 46 · 2024: 55 · 2023: 52 · 2022: 47 · 2021: 73 · 2020: 70 · 2019: 31 · 2018: 50 · 2017: 59 · 2016: 63 · 2015: 46 · 2014: 45 · 2013: 53 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (HL32262-26, P01HL032262, R01HL032259, HL32259-27)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- fetal hemoglobin, BCL11A, globin gene regulation, beta-globin gene cluster, sickle cell disease, beta-thalassemia, erythroid cells, therapeutic target
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, Erythroblasts, Erythropoiesis, Fetal Hemoglobin, Gene Expression Regulation, Multigene Family, Hemoglobinopathies, Histone Deacetylases, Humans, Nuclear Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Down-Regulation, Erythroid Precursor Cells, K562 Cells, Protein Isoforms, Polymorphism, Single Nucleotide, RNA Interference, Erythroid Cells, Cell Line, Tumor, GATA1 Transcription Factor, Mice, beta-Globins, gamma-Globins, Mi-2 Nucleosome Remodeling and Deacetylase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.